Notice: This company has been marked as potentially delisted and may not be actively trading. Range Cancer Therapeutics ETF Rating Add Compare Share Share Ratings Stock AnalysisDividendHeadlinesHoldingsRatingsShort InterestTrends Range Cancer Therapeutics ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.CNCR Aggregate RatingModerate Buy 2.80Holdings in CNCR have an aggregate rating of Moderate Buy based on 470 analyst ratings issued in the past year covering 50 companies (75.2% of the portfolio).CNCR Aggregate Price Target$12.09High Prediction$12.09Average Prediction$12.09Low Prediction$12.09Holdings in CNCR have an aggregate price target of $12.09 and a range of $12.09 to $12.09 covering 50 companies (75.2% of the portfolio).CNCR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy21 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Range Cancer Therapeutics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 CNCR Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.02%RXRXRecursion Pharmaceuticals$6.03-1.0%2.4112 of 5 stars2.40$9.25 53.4%5News CoverageGap UpHigh Trading Volume2.60%GLUEMonte Rosa Therapeutics$6.93+6.5%1.9148 of 5 stars2.67$14.00 102.0%3Analyst DowngradeNews CoverageHigh Trading Volume2.03%IBRXImmunityBio$2.62-1.9%2.1322 of 5 stars3.00$17.38 563.2%3Analyst Forecast1.97%DNAGinkgo Bioworks$10.08+15.3%0.5556 of 5 stars1.60$4.58 -54.6%5News CoverageGap DownHigh Trading Volume1.90%REPLReplimune Group$12.49+4.0%4.5451 of 5 stars3.13$17.29 38.4%8Insider TradeHigh Trading Volume1.87%EXELExelixis$33.29-1.2%4.5006 of 5 stars2.50$32.44 -2.6%18Analyst DowngradeAnalyst RevisionHigh Trading Volume1.83%RVMDRevolution Medicines$44.06+1.8%4.4792 of 5 stars3.09$65.82 49.4%11Insider Trade1.71%XNCRXencor$24.13+0.5%4.3207 of 5 stars3.11$36.56 51.5%9High Trading Volume1.67%BMYBristol-Myers Squibb$57.33+1.8%4.7851 of 5 stars2.25$55.64 -2.9%20High Trading Volume1.64%SWTXSpringWorks Therapeutics$35.59+2.3%2.0071 of 5 stars3.00$69.50 95.3%61.63%MRSNMersana Therapeutics$1.60-8.0%4.3171 of 5 stars2.88$6.00 275.0%8Positive News1.61%ACLXArcellx$75.54+0.4%3.1329 of 5 stars3.13$105.93 40.2%15Positive NewsHigh Trading Volume1.60%SDGRSchrödinger$19.44+0.7%2.3658 of 5 stars2.82$32.90 69.2%11Positive News1.59%ZYMEZymeworks$14.14+4.1%2.7996 of 5 stars2.86$19.17 35.5%7Analyst ForecastNews CoverageGap DownHigh Trading Volume1.57%BPMCBlueprint Medicines$90.14+1.4%2.5363 of 5 stars2.65$123.33 36.8%20Insider Trade1.56%KPTIKaryopharm Therapeutics$0.64-2.2%3.8015 of 5 stars3.00$5.00 687.4%41.53%ELVNEnliven Therapeutics$22.47-1.7%2.7826 of 5 stars3.20$38.25 70.2%5Positive News1.52%CRBUCaribou Biosciences$1.80-0.6%2.2008 of 5 stars3.00$10.20 466.7%4Positive News1.50%ARVNArvinas$18.48+3.6%2.0251 of 5 stars2.93$63.50 243.6%15High Trading Volume1.49%GNLXGenelux$2.27+3.7%0.8843 of 5 stars3.20$18.25 704.0%51.47%MGNXMacroGenics$3.183.543 of 5 stars2.36$7.63 139.8%111.44%HCMHUTCHMED$14.31-2.1%2.5877 of 5 stars2.50$19.00 32.8%2Positive News1.44%DAWNDay One Biopharmaceuticals$12.79+2.6%1.6159 of 5 stars3.00$35.71 179.2%9High Trading Volume1.43%ERASErasca$2.54+3.7%2.0792 of 5 stars2.80$5.90 132.3%5News CoveragePositive News1.40%IMCRImmunocore$28.33-0.3%2.4959 of 5 stars2.54$65.64 131.7%13Short Interest ↓1.39%RPTXRepare Therapeutics$1.323.2522 of 5 stars2.75$7.00 430.3%4High Trading Volume1.38%ZNTLZentalis Pharmaceuticals$3.00+2.4%1.9984 of 5 stars2.44$10.00 233.3%91.36%KYMRKymera Therapeutics$40.66+3.9%2.2647 of 5 stars2.83$53.88 32.5%18Positive News1.35%BNTXBioNTech$113.08+1.6%2.0872 of 5 stars2.82$140.76 24.5%171.34%CMPXCompass Therapeutics$1.38+0.7%2.6583 of 5 stars2.60$6.75 389.1%5Positive NewsGap Down1.34%IOVAIovance Biotherapeutics$7.38+2.2%4.0316 of 5 stars2.89$22.33 202.6%91.33%GERNGeron$3.49-4.6%3.8526 of 5 stars3.09$7.15 104.9%11Short Interest ↓High Trading Volume1.33%NUVBNuvation Bio$2.68-0.4%2.3876 of 5 stars3.00$6.60 146.3%5News CoverageGap DownHigh Trading Volume1.32%AURAAura Biosciences$8.20+1.1%2.5333 of 5 stars3.29$23.00 180.5%7News CoveragePositive NewsHigh Trading Volume1.31%PGENPrecigen$0.76+5.1%3.4635 of 5 stars2.60$7.00 817.9%5Negative News1.30%ACRVAcrivon Therapeutics$6.71+0.3%0.9515 of 5 stars3.00$23.67 252.7%6News Coverage1.29%RCUSArcus Biosciences$15.50+0.3%2.6467 of 5 stars3.00$34.00 119.4%9News CoverageGap DownHigh Trading Volume1.29%YMABY-mAbs Therapeutics$8.28-3.4%2.2437 of 5 stars3.00$20.89 152.3%10News CoverageHigh Trading Volume1.29%SNDXSyndax Pharmaceuticals$13.08+1.8%3.9473 of 5 stars2.90$36.90 182.1%10News CoverageHigh Trading Volume1.28%BMEABiomea Fusion$4.23+3.7%3.902 of 5 stars3.00$39.36 830.6%13Analyst Forecast1.28%JANXJanux Therapeutics$56.83+0.1%3.6707 of 5 stars3.00$89.90 58.2%121.27%ALLOAllogene Therapeutics$1.87+1.6%2.6638 of 5 stars2.75$9.73 420.5%12Gap DownHigh Trading Volume1.26%MRUSMerus$41.85-0.6%2.6066 of 5 stars3.14$85.64 104.6%141.23%INBXInhibrx$14.60+5.2%1.4812 of 5 stars2.002High Trading Volume1.22%NRIXNurix Therapeutics$19.83-1.0%2.5059 of 5 stars2.94$30.35 53.1%17News CoverageHigh Trading Volume1.22%FHTXFoghorn Therapeutics$5.14+3.2%2.8803 of 5 stars2.80$13.80 168.5%5Analyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume1.21%NUVLNuvalent$84.22-0.5%2.1886 of 5 stars2.85$112.60 33.7%13Insider TradeNews CoveragePositive NewsHigh Trading Volume1.21%MRKMerck & Co., Inc.$98.05-1.5%4.9882 of 5 stars2.71$127.13 29.7%21Analyst DowngradeHigh Trading Volume1.17%TSVT2seventy bio$3.14+7.5%2.2152 of 5 stars2.56$9.00 186.6%9Negative News1.17%AUTLAutolus Therapeutics$2.29+2.2%2.5548 of 5 stars3.00$10.40 354.1%5 This page (NASDAQ:CNCR) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Range Cancer Therapeutics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Range Cancer Therapeutics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
